MESTAG
LIVE

Serial Number

79405510

Owner

Mestag Therapeutics Limited

Attorney

Karen Artz Ash

Filing Date

Aug 1, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MESTAG Trademark

Serial Number: 79405510 • Registration: 7854292

MESTAG is a trademark filed by Mestag Therapeutics Limited on August 1, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Mestag Therapeutics Limited (3 trademarks)

Suites 15 and 16,

Entity Type: 99

Trademark Details

Filing Date

August 1, 2024

Registration Date

July 8, 2025

Published for Opposition

May 20, 2025

Goods & Services

Pharmaceutical and medical preparations for the treatment and prevention of cancer, autoimmune diseases, respiratory inflammatory diseases, neuroinflammatory diseases, cardiovascular inflammatory diseases, metabolic inflammatory diseases, joint and musculoskeletal inflammatory diseases, rheumatological diseases, nephritic inflammatory diseases, inflammatory bowel disease and chronic inflammatory skin conditions

Scientific and technological services, namely scientific research, analysis and testing in the field of pharmaceuticals, medicines and medical technology; scientific and technological services, namely research and design in the field of pharmaceuticals, medicines and medical technology; pharmaceutical research and development; pharmaceutical drug development services; medical and scientific research; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; information and advisory services related to all of the aforementioned services

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 19, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 2, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 2, 2026 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 19, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 4, 2026 FICS
FINAL DISPOSITION PROCESSED
Feb 4, 2026 FIMP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 31, 2025 NREP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 8, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 8, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 8, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 20, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 20, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 14, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 16, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2025 TROA
REFUSAL PROCESSED BY IB
Apr 5, 2025 RFNT
NEW REPRESENTATIVE AT IB RECEIVED
Apr 3, 2025 NREP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 19, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 19, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 12, 2025 RFCR
NON-FINAL ACTION WRITTEN
Feb 11, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 7, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 8, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 8, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 3, 2024 REPR